2002/09-2008/2，沈阳药科大学，博士（导师：李松院士，程卯生教授）；2012/04-2013/04，美国加州大学圣迭戈分校纳米工程系，访问学者（合作导师：张良方教授）；现任8040威尼斯副教授、硕士生导师（药物制剂方向）。上海药学会会员、美国药学会AAPS会员。

仿生膜纳米给药系统研究；化学药物、中药新制剂开发

1) Jing Su, Ran Zhang, Yumei Lian, Zul Kamal, Zhongyao Cheng, Yujiao Qiu, Mingfeng Qiu*. Preparation and Characterization of Erythrocyte Membrane-Camouflaged Berberine Hydrochloride-Loaded Gelatin Nanoparticles. Pharmaceutics, 2018, 11, 93.
2) Xiumei Zhang1, Mingfeng Qiu1, Pengcheng Guo, Yumei Lian, Enge Xu, Jing Su*. Autologous Red Blood Cell Delivery of Betamethasone Phosphate Sodium for Long Anti-Inflammation. Pharmaceutics, 2018, 10, 286.
3) Jing Su1, Geyi Liu1, Yumei Lian1, Zul Kamal, Xiao Que, Yujiao Qiu and Mingfeng Qiu*. Preparation and characterization of erythrocyte membrane cloaked PLGA/arsenic trioxide nanoparticles and evaluation of their in vitro antitumor effect. RSC Advances, 2018, 8, 20068-20076.
4) Zhongyao Cheng1, Yumei Lian1, Zul Kamal, Xin Ma, Jianjun Chen, Xinbo Zhou*, Jing Su* and Mingfeng Qiu*. Nanocrystals Technology for Pharmaceutical Science. Current Pharmaceutical Design, 2018, 24, 2497-2507.
5) Daixu Dai, Ruirui Qiao, Jinwei Dao, Jing Su, Chengmin Jiang, Xichang Wang, Mingyuan Gao, Jian Zhong*. Soybean Lecithin-Mediated Nanoporous PLGA Microspheres with Highly Entrapped and Controlled Released BMP-2 as a Stem Cell Platform. Small, 2018:e1800063.
6) Ling Li, Sibo Jiang, Xiaoxun Li, Yao Liu, Jing Su, Jianjun Chen*. Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site. European Journal of Medicinal Chemistry,2018 (151) , 482e494.
7) Binbin Cheng, Weien Yuan, Jing Su, Yao Liu, Jianjun Chen*. Recent advances in small molecule based cancer immunotherapy. European Journal of Medicinal Chemistry, 2017(157), 582e598.
8) Qiqun Qiao1, Ruirui Qiao1, Yuning He, Cuiping Shi, Yao Liu, Hongxun Hao*, Jing Su*, Jian Zhong*. Instrumental Analytical Techniques for the Charaterization of Crystals in Pharmaceutics and Foods. Crystasl Growth Design, 2017,13, 6138-6148.
9) Nan zhang1, Ruirui Qiao1, Jing Su1, Juan Yan, Zhiqiang Xie, Yiquan Qiao, Xichang Wang* ,Jian Zhong*. Recent Advances of Electrospun Nanofibrous Membranes in the Development of Chemosensorsfor Heavy Metal Detection. Small, 2017, 1604293.
10) Yanan Sun1, Jing Su1, Geyi Liu1, Jianjun Chen, Xiumei Zhang, Ran Zhang, Minhan Jiang, Mingfeng Qiu*. Advances of blood cell-based drug delivery systems [J]. European Journal of Pharmaceutical Sciences.2017, 96(1): 115-128.
11) Xuelan Tang, Ping Lu, Mingfeng Qiu, Jianjun Chen, Lin Ma,Yanan Sun,Feng Zheng, Enge Xu, Jing Sheng, Jing Su*. Screening PEGylated Polyethylenimine Derivatives for Safe and Efficient Delivery of Gene Materials [J]. RSC Advances, 2016, 6, 16316-103326.
12) Feng Zheng, Biao Zhang, Yanan Sun, Mingfeng Qiu*, Jing Su*. Evaluation of WO 2011045166 A1, FKBP52-Tau Interaction as novel therapeutical target for treating the neurological disorders involving Tau dysfunction [J]. Expert Opinion on Therapeutic Patents, 2015, 25(7): 831-835.
13) Qin Lin, Yun pengCai, Lin Ma, MingfengQiu*, Jing Su*. Development of a 5-fluorouracil-loaded PLGA microsphere [J]. Oncology Reports.2014, 32(6):2405-2410.
14) Weiwei Gao, Che-Ming Jack Hu, Ronnie Fang, Brian T. Luk, Jing Su, Liangfang Zhang*. Surface functionalization of gold nanoparticles with red blood cell membranes [J]. Advanced Materials. 2013, 25:3549-3553.
15) Yuqiang Wang1, Jing Su1, Ping Lu, Tuo Jin, Shuyan Chen, Jing. Sheng. Hepatocyte-targeting gene transfer mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine derivative[J]. Drug Design, Development and Therapy. 2013, 7:211-221.
16) Yuqiang Wang, Fei Wang, Xiaoqin Deng, Jing Sheng, Shuyan Chen*, Jing Su*. Delivery of therapeutic AGT shRNA by PEG-Bu for hypertension therapy [J].PloS ONE. 2013, 7(8): e68651.
17) Di Liang, Xiujuan Fu,Meiling Liao, Weien Yuan, Jing Su*. Development of dextran microparticles loaded with IL-1Ra of high-encapsulation efficiency and high-bioactivity by a novel method without exposing IL-1Ra to water-oil interfaces [J]. Powder Technology. 2013, 235:299-302.
18) Shengnan Xiang1, Jing Su1, Haijun Tong, Fei Yang, Wenxue Tong , Weien Yuan, Fei Wu, Chuandong Wang , Tuo Jin*, Kerong Dai, Xiaoling Zhang*. Biscarbamate cross-linked low molecular weight PEI for delivering IL-1 receptor antagonist gene to synoviocytes for arthritis therapy [J]. Biomaterials. 2012, 33: 6520-6532.
19) Yuqiang Wang1, Jing Su1*, Fei Wu, Weien Yuan, Ping Lu, Jing Sheng*, Tuo Jin. Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, lowcytotoxicity, and high efficiency for gene delivery [J]. International Journal of Nanomedicine. 2012, 7: 693-704.

现主持国家重大新药创制子课题1项（长循环及具有缓释特性的红细胞载药关键技术研究，2018ZX09711003-008-002），上海市自然科学基金1项（用于糖尿病的红细胞膜载PLGA/盐酸小檗碱纳米粒给药系统构建与评价，18ZR1419700）；结题国家自然科学基金1项、8040威尼斯医工交叉基金3项；作为技术骨干参与多项国家、省部级课题。授权专利13项（12项中国专利、1项香港专利），已在Advance Materials，Small，Biomaterials等药物材料知名期刊发表研究论文多篇，累计发表科研论文50余篇，其中以第1作者或通讯作者发表SCI英文论文20余篇，单篇影响因子最高21.95。